Boston Scientific (BSX)Officer sold ~$5.23M

~$5.23M

Approx. value · 50K sh @ $104.63

178K

Holds after · shares reported

Traded

Aug 1, 2025

Filed

Aug 4, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 29, 2024CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
2. Dec 11, 2024CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
3. May 12, 2025CongressDisclosed sale of BSX — reported range $15,001 - $50,000
4. May 13, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
5. Jun 2, 2025Insider · 1 personInsiders: 2 sales (~$17.1M)
6. Jun 4, 2025InsiderOfficer sold ~$5.8M of BSX shares in the open market
7. Jun 11, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
8. Jun 26, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
9. Jul 1, 2025InsiderOfficer sold ~$5.35M of BSX shares in the open market
10. Jul 25, 2025InsiderDirector sold ~$424K of BSX shares in the open market
11. Jul 29, 2025InsiderDirector sold ~$310K of BSX shares in the open market
12. Jul 31, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
13. Aug 1, 2025 · this disclosureInsiderOfficer sold ~$5.23M of BSX shares in the open market

What came next

1. Aug 1, 2025InsiderOfficer sold ~$1.81M of BSX shares in the open market
2. Aug 4, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
3. Aug 28, 2025FDARecall: Extractor Pro RX Retrieval Balloon Catheter; UPN (REF): (1) M00547030 (9-12mm Below), (2) M00547000 (9-12mm Above);
4. Sep 2, 2025Insider · 1 personInsiders: 2 sales (~$5.3M)
5. Sep 11, 2025FDARecall: TENACIO Pump without InhibiZone; UPN: 72404420;
6. Sep 11, 2025FDARecall: TENACIO Pump with InhibiZone; UPN: 72404429;
7. Sep 11, 2025FDARecall: LGX Preconnect with TENACIO Pump without InhibiZone; UPNs: (1) 72404405 (12CM IP), (2) 72404407 (18CM IP);
8. Sep 11, 2025FDARecall: CXR Preconnect with TENACIO Pump with InhibiZone; UPNs: (1) UPN: 72404461 (12CM PS IZ), (2) 72404462 (14CM PS IZ), (3) 72404463 (16CM PS IZ), (4) 72404464 (18C…
9. Sep 11, 2025FDARecall: CX Preconnect with TENACIO Pump without InhibiZone; UPNs: (1) 72404486 (15CM IP), (2) 72404488 (21CM IP);
10. Sep 11, 2025FDARecall: LGX Preconnect with TENACIO Pump with InhibiZone; UPNs: (1) UPN: 72404450 (12CM PS IZ), (2) 72404451 (15CM PS IZ), (3) 72404452 (18CM PS IZ), (4) 72404453 (21C…
11. Sep 11, 2025FDARecall: CX Preconnect with TENACIO Pump with InhibiZone; UPNs: (1) UPN: 72404430 (12CM PS IZ), (2) 72404431 (15CM PS IZ), (3) 72404432 (18CM PS IZ), (4) 72404433 (21CM…
12. Sep 12, 2025FDAFDA device clearance: LUX-Dx II Insertable Cardiac Monitor (M302); LUX-Dx II+ Insertable Cardiac Monitor (M312)
13. Sep 23, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
14. Sep 24, 2025FDAFDA device clearance: LithoVue Elite Single-Use Digital Flexible Ureteroscope - Standard with pressure monitoring (M0067940000); LithoVue Elite Single-Use Digital Flexible Ureterosc…
15. Sep 26, 2025FDAFDA device clearance: Radial Jaw 4 Pulmonary Biopsy Forceps
16. Oct 9, 2025FDAFDA device clearance: Orca Air/Water and Suction Valves
17. Oct 17, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
18. Oct 22, 2025Company filing · Form 8-K · ResultsReported its results
19. Oct 22, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 22, 2025, John E. Sununu informed Boston Scientific Corporation (the “Company”) that he will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).”
20. Oct 27, 2025InsiderDirector sold ~$1.01M of BSX shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 9 Congress trade reports, 64 fund holdings reports (13F) and 8 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by Joseph Michael Fitzgerald, EVP & Group Pres, Cardiology

• SEC Form 4 at Boston Scientific (BSX)Nov 4, 2025
• SEC Form 4 at Boston Scientific (BSX)Nov 4, 2025
• SEC Form 4 at Boston Scientific (BSX)Nov 4, 2025
• SEC Form 4 at Boston Scientific (BSX)Sep 3, 2025
• SEC Form 4 at Boston Scientific (BSX)Sep 3, 2025

The full history of Joseph Michael Fitzgerald, EVP & Group Pres, Cardiology is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Boston Scientific

• USAspending.gov award recordOct 1, 2026
• USAspending.gov award recordOct 1, 2026
• USAspending.gov award recordOct 1, 2026
• USAspending.gov award recordOct 1, 2026
• USAspending.gov award recordOct 1, 2026
• House Clerk periodic transaction reportSep 25, 2026

Everything OQRO holds on this company is on its BSX page.